Literature DB >> 14670802

The predictive value of bronchiolitis obliterans syndrome stage 0-p.

Ramsey R Hachem1, Murali M Chakinala, Roger D Yusen, John P Lynch, Aviva A Aloush, G Alexander Patterson, Elbert P Trulock.   

Abstract

Bronchiolitis obliterans syndrome (BOS) remains the main cause of graft loss after lung transplantation. Stage 0-p was recently added to the staging criteria to detect early deterioration in allograft function that might presage BOS stage 1. We assessed the predictive value of stage 0-p by retrospectively analyzing spirometric data for 203 adult bilateral lung transplant recipients. The FEV(1) criterion for stage 0-p had a positive predictive value of 79% and a negative predictive value of 82%. In contrast, the FEF(25-75%) criterion for stage 0-p had a positive predictive value of 52% and a negative predictive value of 72%. Fifty-seven percent of subjects who developed stage 0-p by the FEV(1) criterion progressed to stage 1 within 1 year, whereas only 37% of those who developed stage 0-p by the FEF(25-75%) criterion progressed to stage 1 within 1 year. We conclude that the FEV(1) criterion for stage 0-p is a reasonable predictor of BOS stage 1 after bilateral lung transplantation, but the FEF(25-75%) criterion for stage 0-p is not predictive of BOS stage 1 after bilateral lung transplantation.

Entities:  

Mesh:

Year:  2003        PMID: 14670802     DOI: 10.1164/rccm.200307-1018OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  14 in total

1.  Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.

Authors:  Sameem Abedin; Gregory A Yanik; Thomas Braun; Attaphol Pawarode; John Magenau; Steven C Goldstein; John E Levine; Carrie L Kitko; Daniel R Couriel
Journal:  Biol Blood Marrow Transplant       Date:  2015-02-14       Impact factor: 5.742

2.  Association of large-airway lymphocytic bronchitis with bronchiolitis obliterans syndrome.

Authors:  John R Greenland; Kirk D Jones; Steve R Hays; Jeffrey A Golden; Anatoly Urisman; Nicholas P Jewell; George H Caughey; Neil N Trivedi
Journal:  Am J Respir Crit Care Med       Date:  2012-12-13       Impact factor: 21.405

Review 3.  Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.

Authors:  S Samuel Weigt; Ariss DerHovanessian; W Dean Wallace; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

4.  Bronchiolitis obliterans following lung transplantation: early detection using computed tomographic scanning.

Authors:  P A de Jong; J D Dodd; H O Coxson; C Storness-Bliss; P D Paré; J R Mayo; R D Levy
Journal:  Thorax       Date:  2006-05-02       Impact factor: 9.139

5.  Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.

Authors:  Vibha N Lama; Susan Murray; Jeanette A Mumford; Kevin R Flaherty; Andrew Chang; Galen B Toews; Marc Peters-Golden; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2005-05-13       Impact factor: 21.405

6.  Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?

Authors:  Gregory I Snell; Miranda Paraskeva; Glen P Westall
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

7.  Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Kareem Jamani; Qianchuan He; Yang Liu; Chris Davis; Jesse Hubbard; Gary Schoch; Stephanie J Lee; Ted Gooley; Mary E D Flowers; Guang-Shing Cheng
Journal:  Biol Blood Marrow Transplant       Date:  2019-12-09       Impact factor: 5.742

Review 8.  Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis.

Authors:  Jean-François Cordier
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

9.  Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.

Authors:  Guang-Shing Cheng; Barry Storer; Jason W Chien; Madan Jagasia; Jesse J Hubbard; Linda Burns; Vincent T Ho; Joseph Pidala; Jeanne Palmer; Laura Johnston; Sebastian Mayer; Kristina Crothers; Iskra Pusic; Stephanie J Lee; Kirsten M Williams
Journal:  Ann Am Thorac Soc       Date:  2016-11

10.  Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis.

Authors:  Monal Sharma; Muthukumar Gunasekaran; Ranjithkumar Ravichandran; Cynthia E Fisher; Ajit P Limaye; Chengcheng Hu; John McDyer; Vaidehi Kaza; Ankit Bharat; Sofya Tokman; Ashraf Omar; Ashwini Arjuna; Rajat Walia; Ross M Bremner; Michael A Smith; Ramsey R Hachem; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2020-07-07       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.